Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 57 Records) |
| Query Trace: Neoplasms and CYP2C8[original query] |
|---|
| Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis. Acta haematologica 2013 129 (2): 90-5. Zhong Da-Ni, Wu Ji-Zhou, Li Guo-Ji |
| Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
| Analysis of the Functional Polymorphism in the Cytochrome P450 CYP2C8 Gene rs11572080 with Regard to Colorectal Cancer Risk. Frontiers in genetics 2012 3 278. Ladero José M, Agúndez José A G, Martínez Carmen, Amo Gemma, Ayuso Pedro, García-Martín Ele |
| Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status. Cancer causes & control : CCC 2013 May 24 (5): 929-40. Simonsson Maria, Söderlind Viktoria, Henningson Maria, Hjertberg Maria, Rose Carsten, Ingvar Christian, Jernström Hele |
| CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Jun 24 (6): 1472-8. Hertz D L, Roy S, Motsinger-Reif A A, Drobish A, Clark L S, McLeod H L, Carey L A, Dees E |
| Comparative study of polymorphism frequencies of the CYP2D6, CYP3A5, CYP2C8 and IL-10 genes in Mexican and Spanish women with breast cancer. Pharmacogenomics 2013 Oct 14 (13): 1583-92. Alcazar-González Gregorio Antonio, Calderón-Garcidueñas Ana Laura, Garza-Rodríguez María Lourdes, Rubio-Hernández Gabriela, Escorza-Treviño Sergio, Olano-Martin Estibaliz, Cerda-Flores Ricardo Martín, Castruita-Avila Ana Lilia, González-Guerrero Juan Francisco, le Brun Stéphane, Simon-Buela Laureano, Barrera-Saldaña Hugo Alber |
| Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach. Gene 2014 Jun 543 (1): 69-75. Tulsyan Sonam, Chaturvedi Pankaj, Singh Abhishek Kumar, Agarwal Gaurav, Lal Punita, Agrawal Sushma, Mittal Rama Devi, Mittal Balr |
| Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy. Breast cancer research and treatment 2014 May 145 (1): 245-54. Hertz Daniel L, Roy Siddharth, Jack John, Motsinger-Reif Alison A, Drobish Amy, Clark L Scott, Carey Lisa A, Dees E Claire, McLeod Howard |
| Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy. Clinica chimica acta; international journal of clinical chemistry 2014 Jul 434 21-8. Tulsyan Sonam, Agarwal Gaurav, Lal Punita, Mittal Balr |
| SNPs and taxane toxicity in breast cancer patients. Pharmacogenomics 2014 15 (15): 1845-58. Bosó Virginia, Herrero María José, Santaballa Ana, Palomar Laura, Megias Juan E, de la Cueva Helena, Rojas Luis, Marqués María Remedios, Poveda José Luis, Montalar Joaquin, Aliño Salvador |
| Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer. AIMS medical science 0 2 (4): 271-294. Lavender Nicole, Hein David W, Brock Guy, Kidd La Creis |
| Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel. OncoTargets and therapy 2016 9 5073-80. Kus Tulay, Aktas Gokmen, Kalender Mehmet Emin, Demiryurek Abdullah Tuncay, Ulasli Mustafa, Oztuzcu Serdar, Sevinc Alper, Kul Seval, Camci Celaletd |
| Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients. British journal of cancer 2016 Oct . Lam Siu W, Frederiks Charlotte N, van der Straaten Tahar, Honkoop Aafke H, Guchelaar Henk-Jan, Boven Ep |
| Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance). Cancer medicine 2016 Jan . Boora Ganesh K, Kanwar Rahul, Kulkarni Amit A, Abyzov Alexej, Sloan Jeff, Ruddy Kathryn J, Banck Michaela S, Loprinzi Charles L, Beutler Andreas |
| Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment. Pharmacogenetics and genomics 2017 9 27 (11): 402-409. Marcath Lauren A, Deal Allison M, Van Wieren Emily, Danko William, Walko Christine M, Ibrahim Joseph G, Weck Karen E, Jones David R, Desta Zeruesenay, McLeod Howard L, Carey Lisa A, Irvin William J, Hertz Daniel |
| Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese. Cancer chemotherapy and pharmacology 2017 Apr . Tanabe Yuko, Shimizu Chikako, Hamada Akinobu, Hashimoto Kenji, Ikeda Kazutaka, Nishizawa Daisuke, Hasegawa Junko, Shimomura Akihiko, Ozaki Yukinori, Tamura Nobuko, Yamamoto Harukaze, Yunokawa Mayu, Yonemori Kan, Takano Toshimi, Kawabata Hidetaka, Tamura Kenji, Fujiwara Yasuhi |
| Analysis of a gene panel for targeted sequencing of colorectal cancer samples. Oncotarget 2018 3 9 (10): 9043-9060. Jensen Klaus Højgaard, Izarzugaza Jose M G, Juncker Agnieszka Sierakowska, Hansen Rasmus Borup, Hansen Torben Frøstrup, Timshel Pascal, Blondal Thorarinn, Jensen Thomas Skøt, Rygaard-Hjalsted Eske, Mouritzen Peter, Thorsen Michael, Wernersson Rasmus, Nielsen Henrik Bjørn, Jakobsen Anders, Brunak Søren, Sørensen Flemming Bran |
| ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer Patients. Basic & clinical pharmacology & toxicology 2018 Mar . Björn Niclas, Jakobsen Falk Ingrid, Vergote Ignace, Gréen Henr |
| Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers. Archives of gynecology and obstetrics 2019 May . de Castro Clarissa Lourenço, da Costa Junior Luiz Carlos, Lourenço Letícia Vieira, Seba Karine Souza, da Silva Taiana Sousa Lopes, Vianna-Jorge Rosa |
| Pharmacogenomics of osteonecrosis of the jaw. Bone 2019 4 124 75-82. Yang Guang, Singh Sonal, Chen Yiqing, Hamadeh Issam S, Langaee Taimour, McDonough Caitrin W, Holliday L Shannon, Lamba Jatinder K, Moreb Jan S, Katz Joseph, Gong Y |
| Polymorphisms in Phase I (CYP450) Genes CYP1A1 (rs4646421), CYP1B1 (rs1056836), CYP19A1 (rs749292) and CYP2C8 (rs1058930) and Their Relation to Risk of Breast Cancer: A Case-Control Study in Mazandaran Province in North of Iran. Open access Macedonian journal of medical sciences 2019 Aug 7 (15): 2488-2496. Golmohammadzadeh Golpar, Mohammadpour Abbas, Ahangar Nematollah, Shokrzadeh Mohamm |
| ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers. European journal of clinical pharmacology 2020 6 76 (10): 1401-1408. da Costa Junior Luiz Carlos, de Castro Clarissa Lourenço, Freitas-Alves Daniely Regina, Vianna-Jorge Rosane, Santos Paulo Caleb Júnior Li |
| Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer. Oral diseases 2020 Dec . Van Poznak Catherine, Reynolds Evan L, Estilo Cherry L, Hu Mimi, Schneider Bryan Paul, Hertz Daniel L, Gersch Christina, Thibert Jacklyn, Thomas Dafydd, Banerjee Mousumi, Rae James M, Hayes Daniel |
| Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC). ESMO open 2020 Dec 6 (1): 100019. Pellegrino B, Cavanna L, Boggiani D, Zamagni C, Frassoldati A, Schirone A, Caldara A, Rocca A, Gori S, Piacentini F, Berardi R, Brandes A A, Foglietta J, Villa F, Todeschini R, Tognetto M, Naldi N, Bortesi B, Montemurro F, Ardizzoni A, Boni L, Musolino |
| Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis. Clinical and translational science 2022 Jul . Guijosa Alberto, Freyria Ana, Espinosa-Fernandez Jose Rodrigo, Estrada-Mena Francisco J, Armenta-Quiroga Ana Sofía, Ortega-Treviño Maria Fernanda, Catalán Rodrigo, Antonio-Aguirre Bani, Villarreal-Garza Cynthia, Perez-Ortiz Andric |
| Cytochrome P450 oxidoreductase, POR, associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 . Fei Shen, Guanglong Jiang, Santosh Philips, Laura Gardner, Gloria Xue, Erica Cantor, Reynold C Ly, Wilberforce Osei, Xi Wu, Chau Dang, Donald Northfelt, Todd Skaar, Kathy D Miller, George W Sledge, Bryan P Schneid |
| Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The pharmacogenomics journal 2023 1 . Gillis Nancy, Etheridge Amy S, Patil Sushant A, Hayes D Neil, Hayward Michele C, Auman J Todd, Parker Joel S, Innocenti Federi |
| Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study. Gynecologic oncology 2024 5 187 139-144. M Zenatri, T Perennec, C Michon, F Gernier, J-M Grellard, F-X Piloquet, C Dubot-Poitelon, E Kalbacher, O Tredan, P Augereau, P Pautier, L Fey, F Joly, J-S Fren |
| CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients. Scientific reports 2024 4 14 (1): 7922. Hanaa R M Attia, Mahmoud M Kamel, Dina F Ayoub, Shereen H Abd El-Aziz, Mai M Abdel Wahed, Safa N Abd El-Fattah, Mahmoud A Ablel-Monem, Thanaa M Rabah, Amany Helal, Mona Hamed Ibrah |
| Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences. Human genomics 2024 4 18 (1): 40. Mahamadou D Camara, Yitian Zhou, Taís Nóbrega De Sousa, José P Gil, Abdoulaye A Djimde, Volker M Lausch |
- Page last reviewed:Feb 1, 2024
- Content source: